Table 3. Stratified Risk Group by Score and Mortality in the Development and Validation Groups.
Score | Risk group | Development group | Validation group | ||
---|---|---|---|---|---|
Number of patients (%) | Number of deaths (%) | Number of patients (%) | Number of deaths (%) | ||
0–3 | Low | 682 (55.4) | 9 (0.6) | 298 (56.4) | 1 (0.3) |
4–6 | Intermediate | 248 (20.1) | 20 (18.4) | 110 (20.8) | 6 (5.5) |
7–10 | High | 168 (13.6) | 44 (19.4) | 65 (12.3) | 15 (23.1) |
≥11 | Very high | 134 (10.9) | 106 (50.0) | 55 (10.4) | 23 (41.8) |
Overall | 1232 | 179 | 528 | 45 |